שולי רווח נקי: Precision BioSciences, Inc. (DTIL)

The net margin per ruble of revenue on this Precision BioSciences (DTIL) chart from the GURU.Markets service demonstrates market expectations, where the value of -87.50 reflects this status. This trend is driven by the bet on the ARCUS platform and an academic approach to R&D. The model is based on AI solutions without in-house production. Calibrated diagnostic systems and reserved capacities of contract manufacturing plants support stability.
פילוחי נתונים אנליטיים מרוכזים עבור Precision BioSciences, Inc. (DTIL)

Sales margins determine the share of net profit in total revenue, capturing the final efficiency of all trading operations. This metric distinguishes sustainable operating profit from short-term market anomalies. By analyzing actual net profit margins, an investor can observe expense trends and the business's pricing power. For Precision BioSciences (DTIL), this indicator reflects the implementation costs of ARCUS AI platforms. The automation of genome bioscreening should reduce costs, thereby stabilizing profitability.